πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6197754

Suppression of tumor growth by a mini-E1A gene

The Board of Regents of the University of Texas System Β· Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6194481

Mechanically strong and transparent or translucent composites made using zirconium oxide n

The Board of Regents of the University of Texas System Β· Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6194176

Recombinant expression of proteins from secretory cell lines

The Board of Regents of the University of Texas System Β· Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6184254

Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors

The Board of Regents of the University of Texas System Β· Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6184224

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6172212

Pea3 is a tumor suppressor

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6171856

Methods and compositions relating to no-mediated cytotoxicity

The Board of Regents of the University of Texas System Β· Granted Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166193

Polynucleotides encoding MY1 receptor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165990

Antisense polynucleotide

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165745

Recombinant production of immunoglobulin-like domains in prokaryotic cells

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165484

EDTA and other chelators with or without antifungal antimicrobial agents for the preventio

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165461

Tao protein kinases and methods of use therefor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6165440

Radiation and nanoparticles for enhancement of drug delivery in solid tumors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6156321

Tissue factor methods and compositions for coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Dec 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6143290

Tumor regression by adenovirus expression of wild-type p53

The Board of Regents of the University of Texas System Β· Granted Tue Nov 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6140364

Arachidonic acid metabolite, 16-HETE

The Board of Regents of the University of Texas System Β· Granted Tue Oct 31 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6133320

Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6132730

Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6132729

Combined tissue factor and chemotherapeutic methods and compositions for coagulation and t

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6110744

Diminishing viral gene expression by promoter replacement

The Board of Regents of the University of Texas System Β· Granted Tue Aug 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6110889

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Aug 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6107457

Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated c

The Board of Regents of the University of Texas System Β· Granted Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired